- Home
- ORIC vs INMD Comparison
ORIC vs INMD Comparison
Compare ORIC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- INMD
- Stock Information
- Founded
- ORIC 2014
- INMD 2008
- Country
- ORIC United States
- INMD Israel
- Employees
- ORIC N/A
- INMD N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ORIC Health Care
- INMD Health Care
- Exchange
- ORIC Nasdaq
- INMD Nasdaq
- Market Cap
- ORIC 1.1B
- INMD 964.9M
- IPO Year
- ORIC 2020
- INMD 2019
- Fundamental
- Price
- ORIC $12.96
- INMD $14.93
- Analyst Decision
- ORIC Strong Buy
- INMD Hold
- Analyst Count
- ORIC 8
- INMD 6
- Target Price
- ORIC $16.57
- INMD $17.06
- AVG Volume (30 Days)
- ORIC 1.5M
- INMD 812.7K
- Earning Date
- ORIC 11-06-2025
- INMD 11-05-2025
- Dividend Yield
- ORIC N/A
- INMD N/A
- EPS Growth
- ORIC N/A
- INMD 46.63
- EPS
- ORIC N/A
- INMD 2.54
- Revenue
- ORIC N/A
- INMD $401,561,000.00
- Revenue This Year
- ORIC N/A
- INMD N/A
- Revenue Next Year
- ORIC N/A
- INMD $5.14
- P/E Ratio
- ORIC N/A
- INMD $5.89
- Revenue Growth
- ORIC N/A
- INMD N/A
- 52 Week Low
- ORIC $3.90
- INMD $13.14
- 52 Week High
- ORIC $14.93
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- ORIC 53.61
- INMD 45.05
- Support Level
- ORIC $11.71
- INMD $15.03
- Resistance Level
- ORIC $13.80
- INMD $15.86
- Average True Range (ATR)
- ORIC 0.69
- INMD 0.43
- MACD
- ORIC -0.11
- INMD -0.09
- Stochastic Oscillator
- ORIC 50.63
- INMD 5.04
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.